Table 4 Logistic Regression Model of Hyperglycemia as a Risk Factor for Post-procedural Parenchymal Hematoma Type 2 in Patients with Acute Ischemic Stroke of the Anterior Circulation after Endovascular Revascularization Therapy According to Reperfusion Status.

From: Impact of varying levels of hyperglycemia on clinicoradiographic outcomes after endovascular reperfusion treatment

 

Overall (n = 341)

Reperfusion subgroup (n = 272)

Non-reperfusion subgroup (n = 69)

OR (95% CI)

p-value

OR (95% CI)

p-value

OR (95% CI)

p-value

Age

0.99 (0.94–1.04)

0.670

1.00 (0.93–1.04)

0.542

1.000

Sex

1.89 (0.51–6.98)

0.342

1.30 (0.33–5.08)

0.702

1.000

Admission NIHSS score

1.04 (0.92–1.17)

0.583

1.03 (0.90–1.19)

0.634

1.000

IV tPA

0.93 (0.21–4.11)

0.926

1.22 (0.24–6.33)

0.810

0.999

Baseline intracranial occlusion

 

0.048

 

0.111

 

1.000

  ICA T

Reference

 

Reference

 

Reference

 

  ICA I

0.00 (0.00)

0.998

0.00 (0.00)

0.998

1.000

  MCA M1

0.15 (0.03–0.66)

0.012

0.09 (0.02–0.52)

0.007

1.000

  MCA M2 superior

3.66 (0.60–22.21)

0.159

1.42 (0.14–14.36)

0.768

0.999

  MCA M2 inferior

0.00 (0.00)

0.998

0.00 (0.00)

0.999

1.000

Pre-procedure DWI volume

1.01 (1.00–1.03)

0.126

1.01 (1.00–1.03)

0.130

1.000

Onset to puncture

1.00 (1.00–1.01)

0.730

1.00 (1.00–1.01)

0.300

0.999

Final mTICI 2b–3

1.52 (0.28–8.14)

0.624

    

Glucose level

 

0.009

 

0.025

 

1.000

Normoglycemia

Reference

 

Reference

 

Reference

 

Moderate hyperglycemia

0.92 (0.20–4.36)

0.920

1.39 (0.24–8.15)

0.717

1.000

Overt hyperglycemia

9.28 (1.66–51.88)

0.011

12.34 (1.60–95.07)

0.016

1.000

  1. OR, odds ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; IV tPA, intravenous tissue plasminogen activator; ICA, internal carotid artery; MCA, middle cerebral artery; DWI, diffusion-weighted imaging; mTICI, modified Treatment In Cerebral Ischemia.